Unity VCS | Search

Trials

260 participants · First posted Jul 8, 2025

Recruiting

NCT07222150

Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness

105 participants · First posted Oct 29, 2025

Recruiting

NCT07756385

Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)

30 participants · First posted Aug 10, 2026

Drugs

View all 378 →

Small Molecule

Approved

Voclosporin(Lupkynis)

Conditions: Lupus Nephritis

C₆₃H₁₁₁N₁₁O₁₂ · Rx

UniTI-101

neuroblastoma therapy (Childhood Cancer Research Unit)

Organizations

View all 64 →

VCS FOUNDATION LTD

Australia

Unity Biotechnology

United States

Unity Health Toronto

Canada

News

View all 327 →

last year

Alcon Unveils Next-Generation Retinal Surgery Technologies at ASRS Annual Meeting

last year

UNITY Biotechnology's UBX1325 Shows Promise in Diabetic Macular Edema Treatment

last year

Trials

UNITY VCS Vitreoretinal Surgery

Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness

Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)

Drugs

Voclosporin(Lupkynis)

UniTI-101

neuroblastoma therapy (Childhood Cancer Research Unit)

Organizations

VCS FOUNDATION LTD

Unity Biotechnology

Unity Health Toronto

News

Alcon Unveils Next-Generation Retinal Surgery Technologies at ASRS Annual Meeting

UNITY Biotechnology's UBX1325 Shows Promise in Diabetic Macular Edema Treatment

Unity Biotechnology Reports Positive UBX1325 Data and Financial Improvements in Q3 2024